123 Results for "

compound 21

" in MedChemExpress (MCE) Product Catalog:
Products (123)

123 Results for "compound 21" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-139990
CAS No.: 2760584-90-3
Purity:  98.26%
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-3 (compound 21) is a potent and orally active CSF-1R inhibitor (IC50=2.1 nM). CSF1R-IN-3 is a potent antiproliferative activity against colorectal cancer cells. CSF1R-IN-3 inhibits the progression of colorectal cancer by suppressing the migration of macrophages, reprograming M2-like macrophages to the M1 phenotype, and enhancing the antitumor immunity .
loading...
    loading...
Cat. No.: HY-147090
CAS No.: 2750350-39-9
Purity:  99.06%
Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH (Compound 21b) incorporates a ligand for EZH2, and a PROTAC linker, which recruit E3 ligases. Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH (Compound 21b) can be used for the research of lymphoma .
loading...
    loading...
Cat. No.: HY-158201
CAS No.: 2991057-76-0
Purity:  99.29%
ATF4-IN-1 (Compound 21) is an ATF4 inhibitor and also an eIF2B activator. ATF4-IN-1 can be used in research on neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-148949
CAS No.: 2361160-57-6
Purity:  98.96%
Target:  

Kallikrein

Research Areas:  

Others

Kallikrein 5-IN-2 (compound 21) is a selective Kallikrein KLK5 inhibitor (pIC50=7.1). KLK5 inhibition may normalise epidermal shedding and reduce the associated inflammation and itching .
loading...
    loading...
Cat. No.: HY-128133
CAS No.: 236403-25-1
Purity:  99.70%
Synonyms: MMP8-I
Target:  

MMP

Research Areas:  

Cancer

MMP-8 inhibitor-1 (compound 21), a hydroxamic acid derivative, is a potent MMP-8 inhibitor without significant oral bioavailability .
loading...
    loading...
Cat. No.: HY-111040
CAS No.: 946002-48-8
Purity:  99.83%
Target:  

Hedgehog

Research Areas:  

Neurological Disease

Hh agonist 1 (compound 21k) is a potent Hedgehog (Hh) agonist, with an EC50 0.3 nM. Hh agonist 1 can be used for the research of stroke and other neurological disorders .
loading...
    loading...
Cat. No.: HY-148435
CAS No.: 2166378-92-1
Purity:  99.65%
Glucocorticoid receptor agonist-2 (compound 21) is an glucocorticoid receptor agonist with an IC50 value of 6.6 nM. Glucocorticoid receptor agonist-2 can be used to synthesize anti-inflammatory ADC molecules. Glucocorticoid receptor agonist-2 is an active reference of ABBV-3373 .
loading...
    loading...
Cat. No.: HY-132158
CAS No.: 2414594-29-7
Purity:  96.00%
Research Areas:  

Cancer

MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), a camptothecin payload, can be conjugated to a monoclonal antibody (mAb) for the synthesis of camptothecin antibody-drug conjugate (ADC) .
loading...
    loading...
Cat. No.: HY-112262
CAS No.: 1123757-49-2
CGRP antagonist 1 (compound 21) is a highly potent CGRP receptor antagonist with a Ki and an IC50 of 1.7 nM and 5.7 nM, respectively .
loading...
    loading...
Cat. No.: HY-135570
CAS No.: 1644156-80-8
Purity:  99.97%
hDHODH-IN-3 (compound 21d) is a human dihydroorotate dehydrogenase (HsDHODH) inhibitor, inhibits measles virus replication with a pMIC50 value of 8.6 .
loading...
    loading...
Cat. No.: HY-156280
CAS No.: 3053403-01-0
Purity:  99.07%
Target:  

RAR/RXR

Research Areas:  

Endocrinology

RARα antagonist 1 (compound 21) is an orally active and selective retinoic acid receptor α(RARα) antagonist, with the IC50 of 4.6nM .
loading...
    loading...
Cat. No.: HY-149406
CAS No.: 431920-24-0
Purity:  99.68%
Target:  

AMPK TGF-β Receptor

Research Areas:  

Cancer

AMPK activator 12 (compound 21) is a potent AMPK activator and GDF15 inducer. AMPK activator 12 increases GDF15 protein levels in human hepatic cells .
loading...
    loading...
Cat. No.: HY-W130025
CAS No.: 14208-10-7
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

p-Xylene bis(pyridinium bromide) (compound 21), a cationic charged quencher, is a week bisquaternary AChE and BChE inhibitor with IC50s of 1540 μM and 529 μM, respectively .
loading...
    loading...
Cat. No.: HY-W009431
CAS No.: 3779-42-8
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

AChE-IN-84 (compound 21) is an AChE inhibitor .
loading...
    loading...
Cat. No.: HY-161050
CAS No.: 3032969-58-4
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

YSR734 (Compound 21) is a covalent HDAC inhibitor with IC50 values of 110 nM, 154 nM, and 143 nM for HDAC1, HDAC2, and HDAC3, respectively. YSR734 can induce apoptosis in leukemia cells. YSR734 can induce myoblast differentiation and is used in the study of Duchenne muscular dystrophy .
loading...
    loading...
Cat. No.: HY-117865
CAS No.: 2101957-05-3
Purity:  99.81%
Research Areas:  

Cancer

GNE-886 (Compound 21) is a potent and selective inhibitor of Cat eye syndrome chromosome region candidate 2 bromodomain (CECR2) (BRD) with an IC50 value of 0.016 µM and an EC50 value of 370 nM. GNE-886 also inhibits BRD9 with an IC50 value of 1.6 µM .
loading...
    loading...
Cat. No.: HY-149397
CAS No.: 3052551-17-1
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

FXIIa-IN-1-IN-2 (Compound 21) is a Factor XIIa inhibitor (Ki app: 62.2 nM). FXIIa-IN-1-IN-2 can be used for research of thrombosis .
loading...
    loading...
Cat. No.: HY-134597
CAS No.: 2416910-64-8
Purity:  ≥98.0%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-4 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 21. SENP1-IN-4 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
Cat. No.: HY-146206
CAS No.: 2389034-65-3
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

HCAIX-IN-1 (compound 21e) is a potent and selective HCAIX inhibitor with KIs of 694.9, 126.6, 3.3, 9.8 nM for hCA I, hCA II, hCA IX, hCA XII, respectively .
loading...
    loading...
Cat. No.: HY-103461
CAS No.: 1143578-94-2
Purity:  99.70%
Target:  

FAAH

Research Areas:  

Neurological Disease

FAAH-IN-6 (compound 21d) is a potent, orally active and cross the blood-brain barrier fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 0.72, 0.28 nM for hFAAH, rFAAH, respectively. FAAH-IN-6 shows dose-dependent analgesic efficacy in animal models of both neuropathic and inflammatory pain .
loading...
    loading...